The global medication management system market is expected to hold a value worth US$ 2.7 billion in 2023. From 2023 to 2033, the global medication management system market is likely to display a CAGR of 12.4% while garnering US$ 9.0 billion. Growth of the market can be attributed to the increasing investment by hospitals to enhance workflow and rapid development in medical technology.
Medication management software develops inventory management, controls Adverse Drug Events (ADE), and dispenses medicines. In current times, there has been a significant shortage of healthcare professionals and pharmacists. Therefore, to ensure efficient workflow, there has been an increase in the adoption of medication management software.
The adoption of IT in the healthcare culture is likely to benefit the market during the forecast period. The increasing number of prescriptions, the development of technologies, and the growing government reforms and policies boosting the integration of IT in healthcare are projected to fuel the industry in the forecast period.
Persistent challenges faced by healthcare professionals for better management of clinical operations lessened healthcare costs, and streamlined workflow is likely to increase demand for automated solutions in healthcare facilities. Also, increasing prescriptions is likely to boost healthcare institutions' adoption of medication management solutions.
As per a report published by the USA Department of Health and Human Services, the total number of prescriptions in the United States increased from 4.2 billion in 2019 to 6.3 billion by 2020. Also, the American College of Clinical Pharmacy anticipated that more than 5 billion prescriptions would be dispensed by 2021. An increasing number of prescriptions boosts the burden on pharmaceuticals, which is projected to grow the adoption of automated solutions in workflow management.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rising Medication Error to Develop the Global Market
According to the WHO Report 2017, medication error costs about US$ 42 billion globally annually. It has increased demand for medication management systems as a vital part of healthcare infrastructure. As per another report by WHO, by 2020, about 73% of global deaths would be from chronic illness like cardiovascular diseases and cancer, which demands long-term medication with proper medication dispensing and continuous patient monitoring, which can be performed efficiently through medication management system.
The deployment of advanced technologies in medication management is projected to augment the market size in the forecast period. For instance, in August 2019, Pharmazam launched personalized real-time medication management and the healthcare system. Pharmazam’s Pharmacogenetic (PGx) test results consist of a comprehensive DNA test and a sample collected using an FDA-cleared device. Such factors are expected to benefit the market during the forecast period.
Clinical Decision Support System to Gain Significant Traction
Clinical Decision Support System (CDSS) is a healthcare IT system that aims to support clinical decisions for healthcare professionals and physicians. This equipment includes computerized alerts and reminders to care providers and patients, diagnostic support, focused patient data reports, summaries, and documentation templates.
Further, increasing demand for reducing human errors in medication management, growing demand for quality care, and growing adoption rate in emerging economies are the most vital factors expected to boost the expansion of the clinical support segment solutions in the coming time.
Principal Consultant
Heavy Expenses Associated with the Deployment of Medication Management System to Hinder the Market
Heavy expenses associated with the installation, maintenance, and operations are expected to hinder the market in the coming time. Also, lack of expertise in a computerized program and reluctance to adopt modern techniques among evolving economies are other vital factors restraining industry growth in the forecast period.
However, with the growing efforts of manufacturers to develop novel medication management systems, the market can counter hampering factors and aid in market growth in the coming time.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 12.4% |
| Market Valuation (2023) | US$ 2.7 billion |
| Market Valuation (2033) | US$ 9.0 billion |
From 2018 to 2022, the global market is expected to have displayed a CAGR of 8.4%. The development of the market can be attributed to the growing number of hospitals investing in technologies to enhance healthcare process management. Further, key players are adopting various strategies like mergers and acquisitions to gain market share.
For instance, in 2017, McKesson Corporation acquired CoverMyMeds LLC, one of the fastest-growing technology companies in the United States. McKesson has made 21 investments with 23 acquisitions and spent over US$ 18.95 billion for acquisitions. Due to such factors, the global medication management system is anticipated to have displayed significant growth during the period above.
From 2023 to 2032, the global market is anticipated to display a CAGR of 12.4%. The market's growth can be attributed to the increasing demand for reducing human errors, the rising demand to reduce healthcare expenditure, the increasing demand to improve the quality of care, and expanding chronic illness.
Additionally, the launch of new products is expected to benefit the market in the forecast period. For instance, in 2021, Jubilee BioTech developed JUBIwatch, a new device that aims to enhance patients’ medication adherence — taking medicines at the right time with the right dose. Such factors are expected to benefit the market during the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Hospitals to have dominated the market by claiming a 71.1% of Revenue Share in 2023
The hospital segment is anticipated to have dominated the global medication management system market while claiming 71.1% of the global revenue.
The domination of the segment can be attributed to the increasing investment of hospitals to upgrade their IT systems. They aim to enhance workflow efficiency, simplify complex processes, and dispense medication safely.
Pharmacy to Display a CAGR of 11 % during the Forecast Period.
The increasing number of prescriptions and a shortage of pharmacists are anticipated to play the most significant role in developing the global market during the forecast period.
As per the study, the segment is projected to exhibit a CAGR of 11% during the forecast period.
| Countries | Forecast Period Share Between 2023 to 2033 |
|---|---|
| United States | 48.4% |
| Germany | 6.4% |
| Japan | 3.4% |
| Countries | Forecast Period CAGR Between 2023 to 2033 |
|---|---|
| Australia | 10.8% |
| China | 14.9% |
| India | 12.2% |
| United Kingdom | 8.6% |
As per the analysis, North America's medication management system market is expected to dominate the global market. The United States is projected to contribute the maximum to developing the industry in the forecast period. As of 2023, the region is expected to claim 51.7% of the global revenue.
The region's domination can be attributed to the increasing equipment approval by the FDA. For instance, in 2017, The United States Food and Drug Administration approved Abilify MyCite (aripiprazole tablets with sensor), the first drug in the United States with a digital ingestion tracking system.
It has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for treating schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder, and for use as an add-on treatment for depression in adults.
Other factors contributing to the marker development include:
As per the analysis, Europe is expected to show decent growth during the forecast period. In 2023, the region is likely to secure 23.4% of the global revenue. The development of the regional market can be attributed to the increasing focus on cloud-based solutions.
Many players are focusing on developing cloud-based deployment solutions that allow easy information to be shared with clients and stakeholders. The major factor that offers the growth of the medication management system is easy access to information in remote locations using such solutions.
APAC is projected to be the fastest-growing region for the medication management market during the forecast period. In 2023, APAC is expected to secure 18% of global revenue. The development of the market can be attributed to the increasing automation of pharmacies.
Growing demand to minimize medication errors is likely to benefit the market in the coming time. Also, the presence of developing countries like India, China, and South Korea, is likely to become a focal point for expansion in the APAC. Further, the contribution of regional players is likely to augment the market size.
For instance, in 2021, Omnicell, Inc. (US) opened a new software development centre in Bangalore, India, aiming at product innovations to deliver cloud-based infrastructures. Such factors are expected to drive the market in APAC.
TOM Medications (Switzerland), Synapse Medicine (France), Hero (US), AiCure (US), Taking Medicine (UK), Cureatr (US), Pillo Health (US), and Emocha (US) are some of the renowned players in the global medication management market.
Competition Analysis
Key players in the global market include Omnicell, Inc., Cerner Corporation, McKesson Corporation, Medication Management Systems, Inc., Talyst, GE Healthcare, Becton, Dickinson and Company, and Allscripts.
Recent Updates from the Market Include:
| Attributes | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | United States, United Kingdom, Japan, India, China, Australia, Germany |
| Key Segments Covered | Software Type, Mode of Delivery, End User, Region |
| Key Companies Profiled | Omnicell, Inc.; Cerner Corporation; McKesson Corporation; Medication Management Systems, Inc.; Talyst; GE Healthcare; Becton; Dickinson and Company; Allscripts |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
Medication management systems are expected to reach US$ 2.7 billion in 2023.
Cloud-based solutions are expected to dominate the market.
The rapid development of medical technology and increased hospital investments to grow the market.
The United States is expected to dominate the medication management system market.
Omnicell, Inc., Cerner Corporation, and McKesson Corporation dominate the market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Software Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Software Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Software Type, 2023 to 2033
5.3.1. Computerized Physician Order Entry
5.3.2. Clinical Decision Support System Solutions
5.3.3. Electronic Medication Administration Record
5.3.4. Inventory Management Solutions
5.3.5. Other Software Types
5.4. Y-o-Y Growth Trend Analysis By Software Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Software Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End Use, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Use, 2023 to 2033
6.3.1. Hospitals
6.3.2. Pharmacies
6.3.3. Other Healthcare Institutions
6.4. Y-o-Y Growth Trend Analysis By End Use, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End Use, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Mode of Delivery
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Mode of Delivery, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Mode of Delivery, 2023 to 2033
7.3.1. On-Premise Solutions
7.3.2. Web-Based Solutions
7.3.3. Cloud-Based Solutions
7.4. Y-o-Y Growth Trend Analysis By Mode of Delivery, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Mode of Delivery, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Software Type
9.2.3. By End Use
9.2.4. By Mode of Delivery
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Software Type
9.3.3. By End Use
9.3.4. By Mode of Delivery
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Software Type
10.2.3. By End Use
10.2.4. By Mode of Delivery
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Software Type
10.3.3. By End Use
10.3.4. By Mode of Delivery
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Software Type
11.2.3. By End Use
11.2.4. By Mode of Delivery
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Software Type
11.3.3. By End Use
11.3.4. By Mode of Delivery
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Software Type
12.2.3. By End Use
12.2.4. By Mode of Delivery
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Software Type
12.3.3. By End Use
12.3.4. By Mode of Delivery
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Software Type
13.2.3. By End Use
13.2.4. By Mode of Delivery
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Software Type
13.3.3. By End Use
13.3.4. By Mode of Delivery
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Software Type
14.2.3. By End Use
14.2.4. By Mode of Delivery
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Software Type
14.3.3. By End Use
14.3.4. By Mode of Delivery
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Software Type
15.2.3. By End Use
15.2.4. By Mode of Delivery
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Software Type
15.3.3. By End Use
15.3.4. By Mode of Delivery
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Software Type
16.1.2.2. By End Use
16.1.2.3. By Mode of Delivery
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Software Type
16.2.2.2. By End Use
16.2.2.3. By Mode of Delivery
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Software Type
16.3.2.2. By End Use
16.3.2.3. By Mode of Delivery
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Software Type
16.4.2.2. By End Use
16.4.2.3. By Mode of Delivery
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Software Type
16.5.2.2. By End Use
16.5.2.3. By Mode of Delivery
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Software Type
16.6.2.2. By End Use
16.6.2.3. By Mode of Delivery
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Software Type
16.7.2.2. By End Use
16.7.2.3. By Mode of Delivery
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Software Type
16.8.2.2. By End Use
16.8.2.3. By Mode of Delivery
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Software Type
16.9.2.2. By End Use
16.9.2.3. By Mode of Delivery
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Software Type
16.10.2.2. By End Use
16.10.2.3. By Mode of Delivery
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Software Type
16.11.2.2. By End Use
16.11.2.3. By Mode of Delivery
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Software Type
16.12.2.2. By End Use
16.12.2.3. By Mode of Delivery
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Software Type
16.13.2.2. By End Use
16.13.2.3. By Mode of Delivery
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Software Type
16.14.2.2. By End Use
16.14.2.3. By Mode of Delivery
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Software Type
16.15.2.2. By End Use
16.15.2.3. By Mode of Delivery
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Software Type
16.16.2.2. By End Use
16.16.2.3. By Mode of Delivery
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Software Type
16.17.2.2. By End Use
16.17.2.3. By Mode of Delivery
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Software Type
16.18.2.2. By End Use
16.18.2.3. By Mode of Delivery
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Software Type
16.19.2.2. By End Use
16.19.2.3. By Mode of Delivery
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Software Type
16.20.2.2. By End Use
16.20.2.3. By Mode of Delivery
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Software Type
16.21.2.2. By End Use
16.21.2.3. By Mode of Delivery
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Software Type
16.22.2.2. By End Use
16.22.2.3. By Mode of Delivery
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Software Type
16.23.2.2. By End Use
16.23.2.3. By Mode of Delivery
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Software Type
17.3.3. By End Use
17.3.4. By Mode of Delivery
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Omnicell, Inc.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Cerner Corporation
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. McKesson Corporation
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Medication Management Systems, Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Talyst
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. GE Healthcare
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Becton
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Dickinson and Company
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Allscripts
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. QuadraMed Affinity Corporation
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Medication Management System Market
